Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['nivo']
landscape: will this data change patients who are ipi-nivo candidates into cabo-ipi-nivo candidates? or cabo-nivo candidates into cabo-ipi-nivo candidates? we need to see os signal to justify toxicity.
#esmo22 5/n
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe